A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Portfolio optimization could help medtech navigate a perfect storm

by Mark Fedro, principal, Deloitte Consulting LLP and Luis Hakim, senior manager, Deloitte Consulting LLP

Years of growth through acquisition has resulted in a number of large players in the medtech space. Many companies that didn’t appropriately integrate the acquired companies (or their products) are now finding it difficult to effectively manage their extensive and complex product portfolios, which could be restricting their margins and their ability to invest and innovate.

Read more

Medtech companies can add value by uprooting low-value care

by Glenn Snyder, Principal, MedTech Practice Leader, Deloitte Consulting LLP

I’m headed to Philadelphia next week to moderate a panel of medtech CEOs at AdvaMed’s annual conference. Our topic: strategies to reduce low-value care. This is an important issue not just for medtech leaders, but for all health care stakeholders. The cost of low-value care is staggering. In the US alone, medical services that don’t necessarily benefit the patient top $200 billion annually.1

What is low-value care?

Read more

Dr. Robot will see you now: Could artificial intelligence replace your doctor?

by Glenn Snyder, Principal, MedTech Practice Leader, Deloitte Consulting LLP

In the original Star Trek series of the late 1960s, Dr. Leonard “Bones” McCoy relied on technology to diagnose and treat every health condition the crew encountered. But the tricorder didn’t replace the doctor. It enhanced his abilities.

At this week’s Digital Medtech Conference in San Francisco, I will take part in a panel discussion on the benefits and risks of AI and technology in health care.

Read more

Early-stage medtech venture investment is up, driven by digitally-enabled diagnostics. But is the market ready?

by Sonal Shah, Senior Manager, Deloitte Center for Health Solutions, Deloitte Services LP

In my role with the Center for Health Solutions, I spend a fair amount of time researching technology and exploring the impact new medical devices could have on the health care sector. I generally don’t get much first-hand experience with medical devices. That recently changed.

When I told my primary care doctor about some odd sensations I had been feeling in my chest,

Read more

A little less conversation (a little more action) in outcomes-based contracts?

by Mary Cummins, Principal, Deloitte Consulting LLP

I’m recently back from AdvaMed’s annual conference where, as always, I was struck by the deep commitment to bring innovation to patients. But innovation is in the eye of the beholder. When it comes to medtech offerings, there are many stakeholders who decide if an innovation is going to deliver differentiated results, and what value is merited in return.

Read more

In an era of exponentials, health care is on the cusp of a potential major transformation

by Sarah Thomas, Managing Director, Deloitte Center for Health Solutions, Deloitte Services LP

As we look to move the ball forward with health IT, we’re closely watching exponential technologies and their potential power to transform the industry. Exponential technologies have the potential to render the health care sector unrecognizable in a relatively short amount of time. Artificial intelligence (AI), robotics, 3D printing, and synthetic biology all have the ability to potentially dramatically disrupt the systems and processes that have historically defined the health care industry.

Read more